Log-in / Create Account  
 
DIA 2013 49th Annual Meeting
Click here to go to the previous page
Key Multiplicity Issues in Clinical Trials
Track : Track 15: Statistical Science and Quantitative Thinking
Program Code: 143
Date: Monday, June 24, 2013
Time: 2:30 PM to 4:00 PM  EST
Location: 257AB
CHAIR :
 Alex Dmitrienko, PhD (SCHNON), Executive Director, Center for Statistics in Drug Development, Quintiles Inc., United States
SPEAKER (S):
 Mohammad Huque, PhD (SPKAGY), Director, Division of Biometrics IV, Office of Biostatistics, OTS, CDER, FDA, United States
Ralph B. D'Agostino, SR, PhD,MA (SPKSUP), Chair, Mathematics and Statistics Department, Boston University, United States
Alex Dmitrienko, PhD (SPKNON), Executive Director, Center for Statistics in Drug Development, Quintiles Inc., United States
Description
This session will discuss key multiplicity issues arising in confirmatory clinical trials, including commonly used statistical methods, regulatory considerations presented in the draft FDA multiplicity guidance and case studies.

Session Recording
(Code: 143)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON2 Comp Access: Monday Online Access Package - June 24, 2013
Handout Online
(Code: 143)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON2 Comp Access: Monday Online Access Package - June 24, 2013
Key Multiplicity Issues in Clinical Trials